Brief: Pixium Vision Says Experts Confirm PRIMA's Potential To Treat Dry-AMD
March 7 (Reuters) - PIXIUM VISION SA PIX.PA :
* HIGHLIGHTS CONCLUSIONS OF ITS KOL MEETING: EXPERTS CONFIRM
PRIMA’S PROMISES AND POTENTIAL TO TREAT DRY-AMD
* PRIMA CLINICAL PERFORMANCE TO DATE EXCEEDED INITIAL
EXPECTATIONS
IN ADVANCED DRY-AMD
Source text for Eikon: ID:nGNE5S8Fnb
Further company coverage: PIX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow